期刊文献+

65例肥胖高血压患者不同糖耐量状况下血脂及超敏C反应蛋白变化 被引量:1

The Comparison of Lipids and High Sensitivity C-Reactive Protein in Different State of Glucose Tolerance in Obese Hypertensive Patients
下载PDF
导出
摘要 目的研究65例肥胖高血压患者在不同糖耐量状况下血脂及超敏C反应蛋白变化情况。方法收集2012年6月至2013年9月间住院肥胖高血压病人65例,以糖耐量分组,比较两组间胆固醇(CHOL)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)及超敏C反应蛋白(HS-CRP)变化。结果肥胖高血压糖耐量减退组HS-CRP显著高于糖耐量正常组(HS-CRP:NGT vs IGT:1.61±0.95 vs2.27±1.28,P<0.05),两组间胆固醇(CHOL)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)无显著性差异(P>0.05)。结论肥胖高血压患者合并糖耐量减退时,其未来心血管事件发生的潜在风险显著增高,高血压的治疗需对心血管危险因素进行综合干预,全面降低心血管疾病的发病率和死亡率。 Objective To study the changes of lipids and high sensitivity C- reactive protein (HS - CRP) in different state of glucose tolerance in 65 cases of obese hypertensive patients. Methods 65 hospitalized obese hypertensive patients from 6 - 2012 to 9 - 2013 were enrolled. They are devided into normal glucose tolerance group (NGT group) and impaired glucose tolerance group (IGT group). Then we compared HS- CRP, TG, HDL, CHOL, LDL and so on between the IGT group and NGT group by spss 16.0. Results The IGT group has a higher HS- CRP than the NGT group (HS - CRP: IGT group vs NGT group 2.27 ±1.28 vs 1.61± 0.95, P 〈 0.05). Conclusion HS - CRP are higher in the obese hypertensive patients with glucose intolerance. It suggests that the potential cardiovascular danger of the obese hypertensive patients with IGT is higher and the comprehensive intervention is important to the treatment for hypertension.
出处 《内蒙古医学杂志》 2014年第5期515-517,共3页 Inner Mongolia Medical Journal
关键词 肥胖 高血压 糖耐量减退 胰岛素抵抗 HS-CRP obesity hypertension impaired glucose tolerance insulin resistance HS - CRP
  • 相关文献

参考文献9

  • 1Samuel Klein,Lora E.Burke,RN,George A,et al.Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease A Statement for Professionals From the American Heart Association Council on Nutrition,Physical Activity,and Metabolism[J].Circulation,2004,110:2 952-2 967.
  • 2Hiroyuki Hashimoto,Kazuo Kitagawa.C-reactive protein is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis[J].Circulation,2001,104:63.
  • 3Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342:836-843.
  • 4Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men[J].NEnglJMed,1997,336:973-979.
  • 5张健 华强.代谢综合征[M].北京:人民卫生出版社,2003,10.143.
  • 6夏娟,喻明.糖耐量受损:心血管疾病的重要危险因子[J].中国组织工程研究与临床康复,2007,11(51):10344-10348. 被引量:6
  • 7Pradhan AD,Ridker PM.Do atherosclerosis and type 2 diabetes share a common inflammation basis[J].Eur Heart J,2002,23:831-834.
  • 8佟伟军,于亮,刘洋,刘永跃,吴刚,王健,布仁巴图,林哲,张永红,李永山,张显玉.蒙古族农牧民C反应蛋白水平与代谢综合征组分聚集效应的关联性[J].苏州大学学报(医学版),2011,31(6):930-935. 被引量:1
  • 9Ford ES.Body mass index,diabetes,and C-reactive protein a mongU.S.adults[J].Diabetes Care,1999,22(12):1 971-1 977.

二级参考文献26

共引文献19

同被引文献19

  • 1程莹,潘长玉.糖尿病和中间高血糖的定义和诊断(WHO/IDF评议报告)[J].中华内分泌代谢杂志,2006,22(6). 被引量:63
  • 2Futterman LG, Lemberg L. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events[ J ]. Am J Crit Care, 21302,11(5):482-486.
  • 3Klausen KP, Scharling H, Jensen JS. Very low level of microalbu- minuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases [ J ]. J Intern Med, 2006,260 ( 3 ) : 231-237.
  • 4Marsden PA, Dorfman DM, Collins T, et al. Regulated expression of endothelin 1 in glomemlar capillary endothelial cells[ J]. Am J Physiol, 1991,261 (1Pt2) :Fl17-125.
  • 5Yang Z, Xing X, Xiao J, et al. Prevalence of cardiovascular dis- ease and risk factors in the Chinese population with impaired glu- cose regulation: the 2007-2008 China national diabetes and meta- bolic disorders study [ J ]. Exp Clin Endocrinol Diabetes, 2013, 121 (6) :372-374.
  • 6Hsieh SD, Muto T. The superiority of waist-to-height ratio as an anthropometrie index to evaluate clustering of coronary risk factors among non-obese men and women [ J ]. Prev Med, 2005,40 ( 2 ) : 216 -220.
  • 7Muffs DM, Houben AJ, Schram MT, et al. Microvascular dysfunc- tion : an emerging pathway in the pathogenesis of obesity-related in- sulin resistance[J]. Rev Endoer Metab Disord, 2013,14( 1 ) :29- 38.
  • 8Pfieto D, Contreras C, SOnchez A. Endothelial dysfunction, obesi- ty and insulin resistance [ J ]. Curt Vasc Pharmacol, 2014, 1 2 ( 3 ) : 412-426.
  • 9Iantomo M, Carnpia U, Daniele N, et al. Obesity, inflammation and endothelial dysfunction [ J ]. J Biol Regul Homeost Agents, 2014,28(2) :169-176.
  • 10Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insu- lin secretion, and insulin sensitivity in nonobese and obese Japa- nese subjects[J]. Diabetes Care, 1997,20(10) :1562-1568.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部